Maximize Your Impact At Fierce’s Pharma Week 2025
Fierce’s Pharma Week 2025, taking place September 8–10 at the Pennsylvania Convention Center in Philadelphia, is a high-value convergence for leaders shaping the future of pharmaceutical innovation, market access, commercial strategy, and product development. The event brings together executives from biotech, pharma, and health tech firms who are actively making decisions about partnerships, commercialization strategies, pipeline investments, and regulatory pathways.
Participants include C-suite decision-makers, functional leads in market development, clinical operations, data analytics, and strategic alliances. The conversations here directly impact upcoming product launches, long-term vendor relationships, and budgeting allocations. With Vendelux’s enriched attendee list, you can identify exactly who will be attending—along with their role focus, organizational priorities, and current vendor interests. This enables teams to conduct early outreach to the right contacts and show up ready for meaningful business conversations.
How Sales, Marketing and Revops Teams Can Use This Attendee List
The audience at Fierce’s Pharma Week prioritizes evidence-based solutions, real-world implementation timelines, and results that fit into complex healthcare ecosystems. With Vendelux’s enriched conference attendee list, revenue teams can align messaging to specific decision-makers within pharmaceutical commercialization, supply chain, data analytics, or digital innovation divisions.
Segment contacts by role—such as heads of medical affairs, market access leads, or pharma IT directors—to tailor outreach based on their business unit priorities. Initiate contact early with individuals managing technology evaluations, data integrations, or procurement planning. Use precise attendee data to set pre-event meetings with stakeholders who influence buying decisions. During the event, the enriched contacts make it easier to convert casual introductions into actionable post-event follow-ups. After the event, informed follow-up—framed around each attendee’s focus area—helps sustain long-term opportunities beyond initial event engagement.
Timing Is Everything
Fierce’s Pharma Week 2025 runs from September 8 to September 10. With influential decision-makers expected on-site, starting outreach in May or early June gives your team time to align efforts and secure meetings. Use Vendelux’s enhanced attendee information to map strategic conversations to the right stakeholders.
Early engagement increases the likelihood of calendar availability and allows relationship building before the conference begins. Aligning your outreach with the attendee list now sets the foundation for high-value conversations once the doors open in Philadelphia.
What’s Included In The Fierce’s Pharma Week 2025 Attendee List?
Vendelux provides visibility into executives expected to attend Fierce’s Pharma Week 2025 through a combination of organizer-sourced details and predictive insights. Clients can upload their target account list to uncover attendee matches for more focused planning and outreach. The enriched attendee list includes first and last name, job title, company name, company website, location (city, state, country), LinkedIn profile, verified email address, and phone number when available.
Where Is Fierce’s Pharma Week 2025?
The event will be held at the Pennsylvania Convention Center in Philadelphia, United States.
When Is Fierce’s Pharma Week 2025?
Fierce’s Pharma Week 2025 will take place September 8–10, 2025.
What Type Of Event Is Fierce’s Pharma Week 2025?
Fierce’s Pharma Week is a cross-functional event focused on commercial strategy, supply chain, regulatory science, and pharma innovation. The agenda features panel discussions, executive roundtables, keynotes, and dedicated networking sessions geared towards high-level decision-making and collaboration across biopharma disciplines.
How Many People Attend Fierce’s Pharma Week 2025?
Fierce’s Pharma Week 2025 is expected to attract more than 1,500 professionals across the biotech, pharmaceutical, and healthtech sectors. Attendees include senior leaders from global, mid-sized, and emerging firms representing departments such as clinical operations, commercialization, R&D, digital transformation, and regulatory affairs.
